NMSC Coverage From Every Angle
Editor:
Karl D. Lewis, MD
Advertisement
Advertisement

Recent News

Is Rare Genetic Disorder Linked to Development of Squamous Cell Skin Cancer?
Definitive HDR Brachytherapy for Non-Melanoma Skin Cancer
Update on Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
Avelumab: JAVELIN Merkel 200 Trial Translated to Real World
ESMO 2018: Evaluating Response to Avelumab in Metastatic Merkel Cell Carcinoma
ESMO 2018: Cetuximab in Unresectable Cutaneous Squamous Cell Carcinoma
Novel Models for Predicting Skin Cancer Risk
ESMO 2018: Sonidegib Treatment in Advanced Basal Cell Carcinoma
Novel Mechanism of Resistance Identified in Merkel Cell Carcinoma
Is There a Correlation Between Azathioprine and Skin Cancer Development?
Can Artificial Neural Network Help Predict Non-Melanoma Skin Cancer?
FDA Approves Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
Are Current Staging Systems for Cutaneous Squamous Cell Carcinoma Satisfactory?
Are Apps Capable of Accurately Diagnosing Skin Cancer?
Early Recognition of Malignant Skin Lesions Through Smartphone Application
Priority Review Granted by FDA to Pembrolizumab in Merkel Cell Carcinoma
Brian C. Capell, MD, PhD, Receives Award for Skin Cancer Research
Rapamycin and Squamous Cell Carcinoma in Renal Transplant Recipients
FDA Grants Orphan Drug Designation to Treatment of Peripheral T-Cell Lymphoma
AAD 2018: Helping Patients Sort Fact From Internet Fiction on Diet and Skin Health
FDA Grants 510(k) Clearance to Superficial Radiation Therapy for Skin Cancers and Keloids
FDA Approves Monoclonal Antibody for Rare Types of NHL Affecting the Skin
Is Human Papillomavirus Vaccine Effective in Treating Cutaneous Squamous Cell Carcinoma?
Are Flight Attendants at Higher Risk for Non-Melanoma Skin Cancer?
Hike Through Alaska Focuses on Skin Cancer Prevention and Detection
Engineered T Cells Devised to Target Merkel Cell Carcinoma Cells
Update on Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
Treatment of Locally Advanced Basal Cell Carcinoma With Neoadjuvant Vismodegib
ASCO 2018: Neoadjuvant Nivolumab for Resectable Merkel Cell Carcinoma
Noninvasive Detection of Epidermolysis Bullosa–Associated Squamous Cell Carcinoma
FDA to Conduct Priority Review of Cemiplimab for Advanced CSCC
ASCO 2018: Avelumab Continues to Show Benefit in Merkel Cell Carcinoma
ASCO 2018: Cemiplimab Active in Metastatic Cutaneous Squamous Cell Carcinoma
Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.